tiprankstipranks
ImmunityBio (IBRX)
NASDAQ:IBRX
US Market

ImmunityBio (IBRX) Income Statement

Compare
1,303 Followers

ImmunityBio Income Statement

Last quarter (Q4 2024), ImmunityBio's total revenue was $7.55M, an increase of 5333.09% from the same quarter last year. In Q4, ImmunityBio's net income was $-59.16M. See ImmunityBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 14.74M$ 622.00K$ 240.00K$ 934.00K$ 605.00K
Gross Profit
$ 14.74M$ 622.00K$ -23.95M$ 934.00K$ -8.54M
Operating Expenses
$ 358.93M$ 362.87M$ 350.86M$ 331.21M$ 210.82M
Depreciation and Amortization
$ 17.55M$ 18.51M$ 24.19M$ 19.12M$ 9.15M
EBITDA
$ -264.43M$ -436.18M$ -335.51M$ -315.38M$ -187.93M
Operating Income
$ -344.18M$ -362.25M$ -351.30M$ -330.28M$ -220.88M
Other Income/Expenses
$ -69.38M$ -221.64M$ -65.99M$ -19.56M$ -25.36M
Pretax Income
$ -413.56M$ -583.89M$ -417.29M$ -349.84M$ -226.03M
Net Income
$ -413.56M$ -583.20M$ -417.32M$ -349.85M$ -224.19M
Per Share Metrics
Basic EPS
$ -0.59$ -1.15$ -1.04$ -0.90$ -0.59
Diluted EPS
$ -0.59$ -1.15$ -1.04$ -0.90$ -0.59
Weighted Average Shares Outstanding
697.31M 508.64M 399.90M 389.23M 383.18M
Weighted Average Shares Outstanding (Diluted)
700.44M 508.64M 399.90M 389.23M 383.18M
Currency in USD

ImmunityBio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis